Skip to main content

Table 4 Acute and late toxicities

From: Clinical outcomes and patterns of failure of head and neck mucosal melanoma treated with multiple treatment modalities

Event

Grades 1–2

Grade 3–4

Acute toxicities

  

Hematological

  

 Anemia

84 (32.1%)

14 (5.3%)

 Thrombocytopenia

9 (3.4%)

2 (0.8%)

 Leucopenia

23 (8.8%)

5 (1.9%)

 Neutropenia

18 (6.9%)

6 (2.3%)

Nonhematological

  

 Dermatitis

60 (22.9%)

4 (1.5%)

 Mucositis

42 (16.0%

8 (3.1%)

 Dry mouth

16 (6.1%)

4 (1.5%)

 Nausea

46 (17.6%)

9 (3.4%)

 Vomiting

41 (15.6%)

0

 Keratitis

2 (7.7%)

0

Late toxicities

  

Hematological

  

 Anemia

34 (13.0%)

4 (1.5%)

 Thrombocytopenia

2 (0.8%)

0

 Leucopenia

13 (5.0%)

0

 Neutropenia

11 (4.2%)

2 (0.8%)

Nonhematological

  

 Nausea

28 (10.7%)

5 (1.9%)

 Vomiting

18 (6.9%)

2 (0.8%)

 Mucositis

26 (9.9%)

4 (1.5%)

 Nephrotoxicity

8 (3.1%)

1 (0.8%)

 Hepatitis

7 (2.7%)

2 (0.8%)

 Neurotoxicity

4 (1.5%)

0

 Cervical fibrosis

2 (0.8%)

0